Bartonella bacilliformis is the etiologic agent of bartonellosis (Carrion's disease), a biphasic disease that is endemic among inhabitants of the western slopes of the Andes in Columbia, Ecuador, and Peru (11, 14) . The disease consists of a primary, acute, hematic phase characterized by fever, hemolytic anemia, and bacteremia, referred to as Oroya fever. This is followed by a secondary, chronic phase characterized by skin eruptions, referred to as verruga peruana. During the hematic phase, B. bacilliformis parasitizes almost 100% of the erythrocytes, resulting in their premature destruction, and leading to a very severe form of hemolytic anemia. In the secondary phase, B. bacilliformis invades endothelial cells, causing hemangiomas, possibly as a result of hyperproliferation of the terminal vasculature of the dermis and subcutaneous tissue (10). These hemangiomas bear a distinct clinical and histologic similarity to the hemangioma-like lesions of bacillary (epitheliod) angiomatosis (BA), which has now been associated with the newly described bacterium Bartonella henselae (previously, Rochalimaea henselae) (4, 26, 27) . Interestingly, B. bacilliformis and B. henselae are also closely related phylogenetically, and it was suggested that these bacteria may have a common mechanism of pathogenesis (1).
Bartonella bacilliformis is the etiologic agent of bartonellosis (Carrion's disease), a biphasic disease that is endemic among inhabitants of the western slopes of the Andes in Columbia, Ecuador, and Peru (11, 14) . The disease consists of a primary, acute, hematic phase characterized by fever, hemolytic anemia, and bacteremia, referred to as Oroya fever. This is followed by a secondary, chronic phase characterized by skin eruptions, referred to as verruga peruana. During the hematic phase, B. bacilliformis parasitizes almost 100% of the erythrocytes, resulting in their premature destruction, and leading to a very severe form of hemolytic anemia. In the secondary phase, B. bacilliformis invades endothelial cells, causing hemangiomas, possibly as a result of hyperproliferation of the terminal vasculature of the dermis and subcutaneous tissue (10) . These hemangiomas bear a distinct clinical and histologic similarity to the hemangioma-like lesions of bacillary (epitheliod) angiomatosis (BA), which has now been associated with the newly described bacterium Bartonella henselae (previously, Rochalimaea henselae) (4, 26, 27) . Interestingly, B. bacilliformis and B. henselae are also closely related phylogenetically, and it was suggested that these bacteria may have a common mechanism of pathogenesis (1) .
We were interested in isolating and characterizing immunodominant B. bacilliformis antigens because of their potential usefulness in diagnosis and in elucidating the pathogenesis of bartonellosis. Additionally, the presence of homologs of these antigens in B. henselae might be interesting from the standpoint of the pathological similarities between the lesions of verruga peruana and BA. To isolate immunodominant antigens of B. bacilliformis, we constructed a B. bacilliformis genomic DNA library and screened it with serum from a patient with the chronic verruga phase of bartonellosis. In this report, we describe the isolation and initial characterization of one of the clones expressing a 75-kDa antigen of B. bacilliformis. Based on the strong amino acid sequence homology with the cell division protein FtsZ, we suggest that the 75-kDa antigen is the B. bacilliformis homolog of FtsZ (FtsZ Bb ). This is the first study that shows that FtsZ proteins are immunogenic in humans.
Agarose gel electrophoresis. Genomic DNA extracted from cells, as well as restriction digests were electrophoresed through a 0.7% agarose gel. Gels were electrophoresed in Tris-borate buffer containing ethidium bromide and photographed. Tsp509I fragments ranging in size from 3 to 8 kb were extracted from agarose gels using the GENECLEAN (BIO 101 Inc., La Jolla, Calif.) protocol.
Construction of B. bacilliformis genomic library. Total genomic DNA from B. bacilliformis KC584 was partially digested with the restriction endonuclease Tsp509I (New England Biolabs) (65°C for 30 min). Fragments in the size range of 3 to 8 kb were ligated to EcoRI-digested, alkaline phosphatase-treated lambda ZAPII vector arms, using the lambda ZAPII cloning system (Stratagene). The ligation products were packaged in vitro using the GIGAPACK II GOLD packaging system (Stratagene). Packaged lambda phage was then used to infect E. coli XL-1Blue. The titer of the resulting library was approximately 8 ϫ 10 8 recombinant phage/ml.
Library screening. Approximately 50,000 recombinant lambda phage were screened for the production of recombinant proteins that were specific for B. bacilliformis. Filters were blocked overnight with 5% BLOTTO and reacted with the primary antibody, human B. bacilliformis antiserum (diluted 1:200 in 5% BLOTTO), for 2 h using gentle agitation (approximately 80 rpm). The secondary antibody was goat anti-human immunoglobulin G conjugated to horseradish peroxidase, diluted 1:5,000 in 5% BLOTTO (Kirkegaard and Perry Laboratories Inc., Gaithersburg, Md.). Filters were developed using a standard chromogenic substrate (TMB membrane peroxidase substrate system; Kirkegaard and Perry Laboratories Inc.). Positive plaques were picked and purified by plating at successively lower densities. Immunopositive plaques from the final round of purification were subcloned by using the lambda ZAPII in vivo excision method (ExAssist/SOLR system; Stratagene).
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot analysis. E. coli harboring the recombinant plasmids (from the immunopositive plaques) as well as an E. coli negative control harboring pBluescript were induced with isopropyl-␤-D-thiogalactopyranoside (1 mM) to express proteins. Proteins from the bacterial preparations were then solubilized in 1ϫ sample buffer (15) at 100°C and electrophoresed on precast 8 to 16% polyacrylamide gradient gels (NOVEX). Gels were run using Tris-glycine-SDS running buffer. Separated proteins were either stained with Coomassie brilliant blue or electrotransferred onto 0.45-m-pore-size nitrocellulose membranes according to the method of Towbin et al. (32) . The transfer buffer was Tris-glycine with 20% methanol (NOVEX). Transfer was done for 2 h at 100 V with cooling. Membranes were blocked overnight in 5% BLOTTO. The blotting protocol was essentially as described for the nitrocellulose filters, under "Library screening." Membranes were reacted with either human anti-Bartonella serum or E. coli anti-FtsZ serum, and the appropriate secondary antibody (anti-human or antirabbit immunoglobulin G) was used.
DNA sequencing. The nucleotide sequence of both strands of the pIN1 insert was obtained by the methods of Sanger et al. (29) using a model 373A automated nucleic acid sequencer (Applied Biosystems, Foster City, Calif.) and fmol cycle sequencing (Promega). In addition to the T3 and T7 primers, internal sequencing primers were synthesized by using a model 394 DNA synthesizer (Applied Biosystems).
DNA sequence analysis. DNA and protein sequence analyses were performed by using the software packages MacDNAsis (Hitachi Software Engineering America, Ltd., San Bruno, Calif.) and MacVector (International Biotechnologies, Inc., New Haven, Conn.). Multiple sequence alignments were done using the Higgins-Sharp algorithm (Clustal4) of MacDNAsis.
Partial purification of FtsZ Bb . Cells expressing the protein were grown up in a large volume (6 liters) of LB containing ampicillin and induced for protein expression. The culture was concentrated to 1 liter by using a Millipore concentrator (Pellicon; Millipore Corp., Bedford, Mass.). Cells were pelleted, washed once in resuspension buffer (40 mM Tris-HCl [pH 8.0], 5 mM EDTA, 140 mM NaCl, 1 mM dithiothreitol, 10% sucrose, 200 g of phenylmethylsulfonyl fluoride per ml, and COMPLETE protease inhibitor cocktail mix [Boehringer Mannheim], and resuspended in the same buffer (2 ml/g of cells). Resuspended cells were broken by using a French cell press (SLM AMINCO; SLM Instruments, Inc.) by applying a pressure of 8,000 lb/in 2 . The cell lysate was centrifuged at 27,000 ϫ g for 30 min at 4°C in a Beckman model J2-MI ultracentrifuge (Beckman Instruments, Palo Alto, Calif.) using a JA-20 rotor. The supernatant was transferred to a clean tube, and 20% streptomycin sulfate was added, mixed, equilibrated at 0°C for 10 min, and centrifuged as before. Proteins in the supernatant were precipitated by adding ammonium sulfate to a saturation of 25% at 0°C with constant stirring. The suspension was incubated on ice for 1 h and then centrifuged at 27,000 ϫ g for 30 min. The pellet was rinsed with deionized water and resuspended in 5 ml of resuspension buffer.
Photoaffinity cross-linking. A 20-l reaction mixture containing partially purified FtsZ Bb (25% ammonium sulfate fraction from induced cells), 2 g of bovine serum albumin, and 1 M (3,000 Ci/mmol) either [␣- 32 P]GTP or [␣-
32 P]ATP in resuspension buffer was irradiated with UV light (Spectrolinker XL-1000; Spectronics Corp.) for 30 min on ice. The protein was precipitated with 10% trichloroacetic acid, washed once with cold acetone, and resuspended in 1ϫ sample buffer.
PCR amplification. PCR amplifications were performed using a GeneAmp kit from Perkin-Elmer Cetus Corp., Norwalk, Conn. The 100-l reaction mixture consisted of the template, forward and reverse primers, 1ϫ amplification buffer, and a mixture of nucleotides (100 mM). The forward and reverse primers were complementary to the 5Ј and 3Ј ends of ORF-591 respectively. The amplifications were performed in a standard thermal cycler (Perkin-Elmer Cetus Corp.). PCR parameters consisted of 30 cycles of 94°C (1 min)-65°C (1 min)-72°C (1 min) followed by a 30-min extension period at 72°C. PCR products were purified by using the QIAQUICK PCR purification system from QIAGEN, Inc., Chatsworth, Calif., following the manufacturer's instructions.
Nucleotide sequence accession numbers. The nucleotide sequence of the 1,779-bp open reading frame of pIN1 has been deposited in the GenBank data base and has been given the accession number AF007266.
RESULTS

Library screening.
Approximately 50,000 recombinant lambda phage from the B. bacilliformis genomic DNA library were screened with human serum for expression of B. bacilliformisspecific antigens. Eight of the intensely reacting clones were plaque purified for further analysis. Seven of the clones expressed antigens that comigrated with antigenic proteins from cell preparations of the two strains of B. bacilliformis, KC584 and KC583. Two of these expressed an antigen of B. bacilliformis with an apparent molecular mass of 75 kDa (Fig. 1) . One of them, designated pIN1, was used for nucleic acid sequencing.
DNA sequence analysis. The nucleotide sequence of the 2,441-bp insert of pIN1 revealed a 1,779-bp open reading frame capable of encoding a 591-amino-acid protein (ORF-591, Fig. 2 ). ORF-591 is oriented in the same direction as the lacZ promoter on the pBluescript cloning vector and extends from an AUG translational start codon at nucleotide 191 to the UGA stop codon at nucleotide 1969. Located about 8 nucleotides upstream of the start codon is a sequence (AGGAA GG) that is highly homologous to the consensus ribosome binding site for E. coli and other prokaryotes (30) . ORF-591 uses a high percentage of preferred B. bacilliformis codons, as revealed by comparisons with other characterized B. bacilliformis genes (21) . pKKORF, a subclone of pIN1 that encodes ORF-591 on a 1,800-bp segment was found to express the 75-kDa antigen with high efficiency (data not shown) N-terminal sequence analysis of the 75-kDa protein produced by the cells harboring pKKORF revealed an amino acid sequence identical to that predicted for ORF-591 (Fig. 2) .
Analysis of the protein sequence. The amino acid sequence specified by ORF-591 codes for an acidic protein with a predicted molecular mass of 63.4 kDa and an isoelectric point of 4.94. A search through the protein database Swiss-Prot revealed ORF-591 to be highly homologous to the FtsZ family of proteins, exhibiting levels of identity ranging from 20 to 69% (Table 1 ). The FtsZ protein, an essential component of the cell division process, has been reported for both gram-positive and gram-negative bacteria (5, 6) . Alignment of the amino acid sequence of B. bacilliformis ORF-591 with the sequences of FtsZ proteins from Rhizobium melliloti, E. coli, Bacillus subtilis, Micrococcus luteus, Streptomyces coelicolor, Staphylococcus aureus, and Wolbachia species (Fig. 3 ) reveals a striking conservation of sequence, particularly in the N-terminal half of ORF-591 (residues 1 to 320). This region has been reported to contain all of the functionally important domains in the E. coli protein, including a glycine-rich GTP/GDP binding pocket (8, 24) ; two other glycine-rich sequences implicated in GTPase activity (7, 25) ; and a proposed magnesium-binding loop (25 Rm1 (91%) within the N-terminal 300 amino acids falls to 46% for the C-terminal 256 amino acids. A conserved region is apparent at the extreme C termini of the two proteins, where a short stretch of around 14 residues exhibits sequence identity approaching 100%. This short conserved stretch of amino acids is also present at the C-terminal ends of the other FtsZ proteins, with the exception of FtsZ Ml and FtsZ Rm2 . Although the function of this region has not yet been elucidated, its high degree of conservation both in the smaller and larger FtsZ proteins raises the possibility that it is important for FtsZ activity.
The molecular mass of FtsZ Bb as estimated by SDS-PAGE (75 kDa) is about 12 kDa more than the molecular mass predicted from the open reading frame (63 kDa). A slower migration pattern on SDS-PAGE has also been observed with FtsZ Rm1 . In this case, the aberrant migration was attributed to the acidic nature of the protein or an unusual folding pattern (17) . One of these factors may also be the cause of the slower migration of FtsZ Bb .
Interaction of FtsZ Bb with GTP. The conservation of a glycine-rich GTP/GDP binding pocket in FtsZ Bb suggests that the Bartonella protein, like other FtsZ homologs (8, 16, 24) , plays a role as a GTP binding protein. We studied the GTP binding capability of FtsZ Bb by using photoaffinity cross-linking. A mixture consisting of a 25% ammonium sulfate fraction containing the protein and [␣-32 P]GTP was exposed to UV light and analyzed by SDS-PAGE (Fig. 4b) . FtsZ Bb was found to cross-link GTP with high efficiency (lane 1). The lack of apparent cross-linking to [␣- Immunoreactivity of FtsZ Bb . Western blot analysis indicates that the 75-kDa proteins expressed from pIN1 and pKKORF react strongly with antiserum raised against purified E. coli FtsZ (Fig. 5, lanes 3 and 4) . This finding is not unexpected in view of the strong sequence conservation between FtsZ Ec and the N-terminal region of FtsZ Bb . Moreover, all of the epitopes that have been mapped in FtsZ Ec are conserved in FtsZ Bb (Fig.  6) . These extracts contain a second protein of approximately 40 kDa that is also detected by the anti-FtsZ Ec antibodies. The size of this protein and the fact that it is observed in control cells lacking ORF-591 suggest that it corresponds to the FtsZ homolog encoded by E. coli (FtsZ Ec ). Surprisingly, the antiBartonella antiserum failed to detect a protein of this size in the E. coli strain used for the construction of the B. bacilliformis gene library (Fig. 1) , even though these cells would be expected to contain endogenous FtsZ Ec . This apparent lack of reactivity on the part of FtsZ Ec with the Bartonella antiserum suggests that the epitopes responsible for the antigenicity of FtsZ Bb in the human serum are not shared by its E. coli counterpart.
A fortuitous observation has led us to theorize that the antiFtsZ antibodies generated during infection with B. bacilliformis are directed predominantly against epitopes located in the Cterminal region of the protein. We have observed that, upon storage, the 75-kDa protein is broken down into four smaller immunoreactive fragments. Each of these fragments is immunoreactive only with one type of antiserum: three can be detected by the anti-Bartonella human serum but are not recognized by anti-FtsZ Ec antibodies, while a fourth reacts solely with antibodies raised against the E. coli protein (data not shown). N-terminal sequence analysis of two of the anti-Bartonella immunoreactive fragments indicates that they are derived from the C-terminal half of FtsZ Bb , while the fragment reacting only with the anti-FtsZ Ec serum is derived from the N-terminal end (Table 2 ). These observations, like the results presented above, suggest that the epitopes on FtsZ Bb recognized by the human antiserum are not shared by the E. coli protein and, further, localize them to the C-terminal, nonhomologous region of the protein. The photoaffinity cross-linking experiments also reveal a GTP binding protein of approxi- (Fig. 4) . Since it is observed only under conditions where expression of FtsZ Bb is induced from pKKORF (Fig. 4b, lanes 1 and 2) , it is possible that the 43-kDa GTP binding protein corresponds to the N-terminal degradation fragment of this size that was observed upon storage of FtsZ Bb . If so, this observation provides evidence supporting the assignment of the GTP binding region to the N-terminal domain of the Bartonella protein.
PCR amplification of the FtsZ gene sequence from B. henselae DNA. To determine if the closely related B. henselae had an FtsZ gene homologous to that of B. bacilliformis, we subjected a sample of B. henselae genomic DNA to PCR amplification conditions using primers complementary to regions near the 5Ј and 3Ј ends of the B. bacilliformis FtsZ gene. The sequences of the primers were as follows: forward primer, 5Ј GCTTGGCGCAGCAGTGA 3Ј; reverse primer, 5Ј ACGTA AAAATGCTGGTATTTC 3Ј. An amplification product was consistently detected with B. henselae DNA, with a size (1,591 bp) that corresponds closely to that of the amplification product from the B. bacilliformis genomic DNA template (Fig. 7) .
DISCUSSION
In this report we describe the construction of a B. bacilliformis genomic library using B. bacilliformis strain KC584 and the isolation of a clone that expresses a 75-kDa antigen of B. bacilliformis. A 75-kDa antigen was previously described as one of the two main antigens of B. bacilliformis since it consistently showed strong reactivity in immunoassays (13) . Additionally, it was found to be one of the three antigens that could detect persisting antibodies in patients. The amino acid sequence of the 75-kDa protein encoded by ORF-591 bears a very high degree of homology to the FtsZ family of proteins. We suggest that the 75-kDa antigen is an FtsZ homolog of B. bacilliformis.
Studies with E. coli have shown that FtsZ plays a central role in bacterial cell division, since it initiates the process by forming a cytokinetic ring at the division site (16) . This leads to the circumferential invagination of the cytoplasmic membrane and cell wall, followed by formation of the division septum. The ring formation is facilitated by the ability of FtsZ monomers to self-assemble, a process that is dependent on the GTPase function of FtsZ (9, 22) . The GTP binding domain of FtsZ (GGG TGTG) bears a remarkable similarity to the GTP binding domains of the eukaryotic tubulins (GGGTGSG), which suggests that FtsZ molecules polymerize in a manner analogous to the tubulins.
The central role of FtsZ in cell division is reflected in its strong conservation among eubacteria. Homologs of FtsZ, all with a high degree of sequence similarity, have been reported in several bacteria (2, 5, 12, (17) (18) (19) . The alignment of the amino acid sequence of FtsZ Bb with the sequences of previously characterized FtsZ proteins shows several blocks of sequences in the N-terminal domain to be conserved (Fig. 3) . The glycine-rich GTP binding pocket and other regions proposed to be involved in the GTPase activity of FtsZ ( The feature that distinguishes FtsZ Bb from most of the other FtsZ proteins characterized to date is the presence of a 256-residue tail at the C terminus. This is a property that it shares only with the R. melliloti FtsZ homolog, FtsZ Rm1 . The function of this C-terminal domain is unknown. All of the domains identified to be necessary for the activity of FtsZ in cell division (17) are located in the N-terminal 300 residues of both FtsZ Bb and FtsZ Rm1 . The C-terminal tail may therefore play a role within the cell that has not been previously associated with FtsZ proteins. In FtsZ Rm1 , this region consists of a high proportion of proline and glutamine repeats, which were predicted to form a stacked ␤-sheet secondary structure (17) . The Cterminal tail of FtsZ Bb has a high content of serine and glutamine residues, making it very hydrophilic. It is therefore possible that this domain lies in an aqueous environment such as the outside of the protein or the outside of the bacterial cell.
Analysis of the amino acid sequence of FtsZ Bb predicts the conservation of all epitopes that have been mapped in its E. coli counterpart (33; Fig. 6 ). This expectation is confirmed by the strong reactivity exhibited by FtsZ Bb with the E. coli FtsZ antiserum (Fig. 5) . On the other hand, we were unable to detect E. coli FtsZ with anti-Bartonella antiserum. This observation, plus the apparent nonreactivity of the N-terminal fragment of FtsZ Bb with the anti-Bartonella antiserum, suggests that the epitopes recognized by the human serum lie within the unique C-terminal region of FtsZ Bb . Theoretical predictions based on hydrophilicity, surface probability, and flexibility indicate that this region has a high proportion of antigenic sites (Fig. 6) . Taken together, our findings suggest that the C-terminal domain of FtsZ Bb is the region that elicits the predominant immunogenic response during the infectious process.
It is not known whether B. bacilliformis undergoes lysis in the infected host. However, if the anti-Bartonella antibodies in the human serum used for these studies are directed against intact bacteria, it is possible that at least part of the 75-kDa antigen, most likely its C-terminal domain, is exposed on the surface of the cell. If so, the subcellular location of FtsZ Bb would differ from that of most organisms studied to date (3), for which FtsZ has been reported to be located primarily in the cytoplasm. Earlier reports indicate the presence of an antigen the size of FtsZ Bb (75 kDa) in membrane preparations of B. bacilliformis (13, 20 75-kDa antigen may not actually be involved in the ring structure normally associated with FtsZ function and that this role is carried out by the product of another, as yet undetected, ftsZ gene that lacks the C-terminal coding region. A second FtsZ homolog (FtsZ Rm2 ) that lacks the C-terminal extension was identified in R. melliloti (18) ; however, this homolog was found to be nonessential for viability. Southern hybridization of the B. bacilliformis genome to the cloned ftsZ Bb gene did not reveal any restriction fragments that could be attributed to a second ftsZ gene (data not shown). Thus, we have no evidence at this time to indicate that a second FtsZ homolog is encoded on B. bacilliformis DNA.
It is possible that a fraction of the newly synthesized 75-kDa molecules is cleaved following synthesis, thereby producing a subset of proteolytic fragments that are capable of forming a cell division structure analogous to the ring structures found in other bacteria. It is worth noting that a short segment within the C-terminal domain of FtsZ Bb is homologous to the light chain of the rat hepatocyte growth factor (HGF), the cleavage of which is essential for activation of the protein (31) (Fig. 8) . Coincidentally, the amino acid sequence that FtsZ Bb shares with HGF has been reported to be homologous to the serine protease domain of plasmin.
The amplification of a DNA segment from B. henselae with primers specific for B. bacilliformis ftsZ suggests that B. henselae also contains a large FtsZ homolog. Moreover, when extracts of B. henselae are reacted with E. coli FtsZ antiserum, an immunoreactive band of approximately 75 kDa is detected (data not shown). The discovery of FtsZ homologs that are twice the size of the conventional FtsZ proteins in these Bartonella strains raises the possibility that large FtsZ proteins form a distinct subgroup of FtsZ homologs with the potential for dual or multiple functions. A large FtsZ protein in the plant pathogen Agrobacterium tumefaciens has also been reported (5) . Interestingly, all of these bacteria belong to the ␣-2 subgroup of the class Proteobacteria (23) . Coincidentally, members of this subgroup are also known to interact closely with eukaryotic cells. In the case of Bartonella, this interaction results in the hemangioma-like lesions of BA. Thus, it appears that some component of the infection process induces the proliferation of eukaryotic cells. Recently, we have observed that endothelial cells preferentially bind partially purified FtsZ Bb (unpublished observations). Characterization of this interaction may enable us to determine the precise role of this FtsZ homolog during B. bacilliformis infection.
